Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling

Oncogene

Volumn 31, Issue 43, 2012, Pages 4639-4646

  Brimer, N ^a   Lyons, C ^a   Wallberg, A E ^b   Vande Pol, S B ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CBF1; epithelial; RBP J; RBP Jk; squamous; transformation

Indexed keywords

INTEGRIN; KERATIN; NOTCH RECEPTOR; PROTEIN E6; TRANSCRIPTION FACTOR HES 1;

ARTICLE; BOVINE PAPILLOMAVIRUS TYPE 1; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 1; HUMAN PAPILLOMAVIRUS TYPE 8; KERATINOCYTE; MASTERMIND LIKE 1 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS GENE; WART VIRUS;

DNA-BINDING PROTEINS; HUMANS; PAPILLOMAVIRIDAE; PROMOTER REGIONS, GENETIC; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; SKIN; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; VIRAL PROTEINS;

BOVINE PAPILLOMAVIRUS TYPE 1; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRIDAE;

EID: 84867899491     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.589     Document Type: Article

References (77)

1. zur Hausen H. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 2009; 384: 260-265.
2. Rous P, Beard JW. The progression to carcinoma of virus-induced rabbit Papillomas (Shope). J Exp Med 1935; 62: 523-548.
3. Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006; 18: 362-374. (Pubitemid 44511885)
4. Green H. Terminal differentiation of cultured human epidermal cells. Cell 1977; 11: 405-416. (Pubitemid 8139151)
5. Adams JC, Watt FM. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 1989; 340: 307-309. (Pubitemid 19189690)
6. Watt FM, Kubler MD, Hotchin NA, Nicholson LJ, Adams JC. Regulation of keratinocyte terminal differentiation by integrin-extracellular matrix interactions. J Cell Sci 1993; 106(Pt 1): 175-182. (Pubitemid 23286789)
7. Dotto GP. Notch tumor suppressor function. Oncogene 2008; 27: 5115-5123.
8. Watt FM, Estrach S, Ambler CA. Epidermal notch signalling: differentiation, cancer and adhesion. Curr Opin Cell Biol 2008; 20: 171-179.
9. Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 2001; 20: 3427-3436. (Pubitemid 32634350)
10. Blanpain C, Lowry WE, Pasolli HA, Fuchs E. Canonical Notch signaling functions as a commitment switch in the epidermal lineage. Genes Dev 2006; 20: 3022-3035. (Pubitemid 44771736)
11. Moriyama M, Durham AD, Moriyama H, Hasegawa K, Nishikawa S, Radtke F et al. Multiple roles of Notch signaling in the regulation of epidermal development. Dev Cell 2008; 14: 594-604. (Pubitemid 351479935)
12. Tanigaki K, Honjo T. Two opposing roles of RBP-J in Notch signaling. Curr Top Dev Biol 2010; 92: 231-252.
13. Artavanis-Tsakonas S, Muskavitch MA. Notch: the past, the present, and the future. Curr Top Dev Biol 2010; 92: 1-29.
14. Saint Just Ribeiro M, Wallberg AE. Transcriptional mechanisms by the coregulator MAML1. Curr Protein Pept Sci 2009; 10: 570-576.
15. Wu L, Aster JC, Blacklow SC, Lake R, Artavanis-Tsakonas S, Griffin JD. MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet 2000; 26: 484-489.
16. Fryer CJ, Lamar E, Turbachova I, Kintner C, Jones KA. Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. Genes Dev 2002; 16: 1397-1411. (Pubitemid 34615092)
17. Saint Just Ribeiro M, Hansson ML, Wallberg AE. A proline repeat domain in the Notch co-activator MAML1 is important for the p300-mediated acetylation of MAML1. Biochem J 2007; 404: 289-298. (Pubitemid 46849600)
18. Chow LT, Broker TR. Papillomavirus DNA replication. Intervirology 1994; 37: 150-158. (Pubitemid 24350683)
19. Stubenrauch F, Laimins LA. Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol 1999; 9: 379-386. (Pubitemid 30184507)
20. Chen JJ, Hong Y, Rustamzadeh E, Baleja JD, Androphy EJ. Identification of an alpha helical motif sufficient for association with papillomavirus E6. J Biol Chem 1998; 273: 13537-13544. (Pubitemid 28268395)
21. Elston RC, Napthine S, Doorbar J. The identification of a conserved binding motif within human papillomavirus type 16 E6 binding peptides, E6AP and E6BP. J Gen Virol 1998; 79(Pt 2): 371-374. (Pubitemid 28048442)
22. Vande Pol SB, Brown MC, Turner CE. Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene 1998; 16: 43-52. (Pubitemid 28043506)
23. Tong X, Boll W, Kirchhausen T, Howley PM. Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1. J Virol 1998; 72: 476-482. (Pubitemid 28048861)
24. Tong X, Howley PM. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc Natl Acad Sci USA 1997; 94: 4412-4417. (Pubitemid 27194255)
25. Bohl J, Das K, Dasgupta B, Vande Pol SB. Competitive binding to a charged leucine motif represses transformation by a papillomavirus E6 oncoprotein. Virology 2000; 271: 163-170. (Pubitemid 30341525)
26. Wade R, Brimer N, Vande Pol S. Transformation by bovine papillomavirus type 1 E6 requires paxillin. J Virol 2008; 82: 5962-5966. (Pubitemid 351822269)
27. Ronco LV, Karpova AY, Vidal M, Howley PM. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 1998; 12: 2061-2072. (Pubitemid 28323879)
28. Huibregtse JM, Scheffner M, Howley PM. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol 1993; 13: 4918-4927. (Pubitemid 23220397)
29. Huibregtse JM, Scheffner M, Howley PM. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 1991; 10: 4129-4135. (Pubitemid 21905444)
30. Huibregtse JM, Scheffner M, Howley PM. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol 1993; 13: 775-784. (Pubitemid 23040242)
31. Scheffner M, Huibregtse JM, Howley PM. Identification of a human ubiquitinconjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc Natl Acad Sci USA 1994; 91: 8797-8801.
32. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993; 75: 495-505. (Pubitemid 23335075)
33. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-1136. (Pubitemid 120035062)
34. Das K, Bohl J, Vande Pol SB. Identification of a second transforming region in bovine papillomavirus type 1 E6 and the role of E6 interaction with paxilin, E6BP, and E6AP. J Virol 2000; 74: 812-816. (Pubitemid 30036217)
35. Cooper B, Brimer N, Stoler M, Vande Pol SB. Suprabasal overexpression of beta-1 integrin is induced by bovine papillomavirus type 1. Virology 2006; 355: 102-114. (Pubitemid 44585048)
36. Kaiser HW, Ness W, Offers M, O'Keefe EJ, Kreysel HW. Talin: adherens junction protein is localized at the epidermal-dermal interface in skin. J Invest Dermatol 1993; 101: 789-793. (Pubitemid 23357486)
37. Yedvobnick B, Smoller D, Young P, Mills D. Molecular analysis of the neurogenic locus mastermind of Drosophila melanogaster. Genetics 1988; 118: 483-497. (Pubitemid 18087680)
38. Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M et al. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 2003; 33: 416-421. (Pubitemid 36278861)
39. Pan Y, Lin MH, Tian X, Cheng HT, Gridley T, Shen J et al. Gamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis. Dev Cell 2004; 7: 731-743. (Pubitemid 39462693)
40. Yamamoto N, Tanigaki K, Han H, Hiai H, Honjo T. Notch/RBP-J signaling regulates epidermis/hair fate determination of hair follicular stem cells. Curr Biol 2003; 13: 333-338. (Pubitemid 36230025)
41. Proweller A, Tu L, Lepore JJ, Cheng L, Lu MM, Seykora J et al. Impaired Notch signaling promotes de novo squamous cell carcinoma formation. Cancer Res 2006; 66: 7438-7444. (Pubitemid 44289196)
42. Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N et al. Wholegenome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101-105.
43. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991; 66: 649-661. (Pubitemid 121001701)
44. Lee SY, Kumano K, Nakazaki K, Sanada M, Matsumoto A, Yamamoto G et al. Gainof-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma. Cancer Sci 2009; 100: 920-926.
45. Klinakis A, Lobry C, Abdel-Wahab O, Oh P, Haeno H, Buonamici S et al. A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature 2011; 473: 230-233.
46. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011; 333: 1154-1157.
47. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011; 333: 1157-1160.
48. Baldus CD, Thibaut J, Goekbuget N, Stroux A, Schlee C, Mossner M et al. Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute Tlymphoblastic leukemia. Haematologica 2009; 94: 1383-1390.
49. Daniel B, Rangarajan A, Mukherjee G, Vallikad E, Krishna S. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J Gen Virol 1997; 78(Pt 5): 1095-1101. (Pubitemid 27207596)
50. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis-Tsakonas S. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci USA 1995; 92: 6414-6418.
51. Ramdass B, Maliekal TT, Lakshmi S, Rehman M, Rema P, Nair P et al. Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression. Gynecol Oncol 2007; 104: 352-361. (Pubitemid 46135657)
52. Rangarajan A, Syal R, Selvarajah S, Chakrabarti O, Sarin A, Krishna S. Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt. Virology 2001; 286: 23-30. (Pubitemid 32675462)
53. Pang RT, Leung CO, Ye TM, Liu W, Chiu PC, Lam KK et al. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 2010; 31: 1037-1044.
54. Rasul S, Balasubramanian R, Filipovic A, Slade MJ, Yague E, Coombes RC. Inhibition of gamma-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells. Br J Cancer 2009; 100: 1879-1888.
55. Sun XM, Wen HW, Chen CL, Liao QP. [Expression of Notch intracellular domain in cervical cancer and effect of DAPT on cervical cancer cell]. Zhonghua Fu Chan Ke Za Zhi 2009; 44: 369-373.
56. Yu H, Huang SL, Zhao XP, Lu J, Qian GX, Ge SF. [Effect of CRE-dependent RNA interference targeting Notch1 on proliferation of cervical cancer cell line HeLa]. Ai Zheng 2007; 26: 148-153.
57. Song LL, Peng Y, Yun J, Rizzo P, Chaturvedi V, Weijzen S et al. Notch-1 associates with IKKalpha and regulates IKK activity in cervical cancer cells. Oncogene 2008; 27: 5833-5844.
58. Talora C, Cialfi S, Segatto O, Morrone S, Kim Choi J, Frati L et al. Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways. Exp Cell Res 2005; 305: 343-354. (Pubitemid 40462545)
59. Talora C, Sgroi DC, Crum CP, Dotto GP. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev 2002; 16: 2252-2263. (Pubitemid 35013088)
60. Wang L, Qin H, Chen B, Xin X, Li J, Han H. Overexpressed active Notch1 induces cell growth arrest of HeLa cervical carcinoma cells. Int J Gynecol Cancer 2007; 17: 1283-1292. (Pubitemid 350077350)
61. Yao J, Duan L, Fan M, Yuan J, Wu X. Notch1 induces cell cycle arrest and apoptosis in human cervical cancer cells: involvement of nuclear factor kappa B inhibition. Int J Gynecol Cancer 2007; 17: 502-510. (Pubitemid 46426786)
62. Lathion S, Schaper J, Beard P, Raj K. Notch1 can contribute to viral-induced transformation of primary human keratinocytes. Cancer Res 2003; 63: 8687-8694. (Pubitemid 38064045)
63. Kurooka H, Honjo T. Functional interaction between the mouse notch1 intracellular region and histone acetyltransferases PCAF and GCN5. J Biol Chem 2000; 275: 17211-17220. (Pubitemid 30398970)
64. Wallberg AE, Pedersen K, Lendahl U, Roeder RG. p300 and PCAF act cooperatively to mediate transcriptional activation from chromatin templates by notch intracellular domains in vitro. Mol Cell Biol 2002; 22: 7812-7819. (Pubitemid 35217292)
65. Oswald F, Tauber B, Dobner T, Bourteele S, Kostezka U, Adler G et al. p300 acts as a transcriptional coactivator for mammalian Notch-1. Mol Cell Biol 2001; 21: 7761-7774. (Pubitemid 32988785)
66. Zhao Y, Katzman RB, Delmolino LM, Bhat I, Zhang Y, Gurumurthy CB et al. The Notch regulator MAML1 interacts with p53 and functions as a coactivator. J Biol Chem 2007; 282: 11969-11981. (Pubitemid 47100726)
67. Shen H, McElhinny AS, Cao Y, Gao P, Liu J, Bronson R et al. The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis. Genes Dev 2006; 20: 675-688.
68. Alves-Guerra MC, Ronchini C, Capobianco AJ. Mastermind-like 1 is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival. Cancer Res 2007; 67: 8690-8698. (Pubitemid 47437444)
69. Lefort K, Mandinova A, Ostano P, Kolev V, Calpini V, Kolfschoten I et al. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases. Genes Dev 2007; 21: 562-577. (Pubitemid 46409471)
70. Melar-New M, Laimins LA. Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol 2010; 84: 5212-5221.
71. Allen-Hoffmann BL, Schlosser SJ, Ivarie CA, Sattler CA, Meisner LF, O'Connor SL. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J Invest Dermatol 2000; 114: 444-455. (Pubitemid 30415329)
72. Hsieh JJ, Henkel T, Salmon P, Robey E, Peterson MG, Hayward SD. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol Cell Biol 1996; 16: 952-959. (Pubitemid 26061666)
73. Kutner RH, Zhang XY, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 2009; 4: 495-505.
74. Jin YH, Kim H, Oh M, Ki H, Kim K. Regulation of Notch1/NICD and Hes1 expressions by GSK-3alpha/beta. Mol Cells 2009; 27: 15-19.
75. Ohashi S, Natsuizaka M, Yashiro-Ohtani Y, Kalman RA, Nakagawa M, Wu L et al. NOTCH1 and NOTCH3 coordinate esophageal squamous differentiation through a CSL-dependent transcriptional network. Gastroenterology 2010; 139: 2113-2123.
76. Peng S, Hua J, Cao X, Wang H. Gelatin induces trophectoderm differentiation of mouse embryonic stem cells. Cell Biol Int 2010; 35: 587-591.
77. Gyuris J, Golemis E, Chertkov H, Brent R. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 1993; 75: 791-803. (Pubitemid 23346376)